Primary systemic amyloidosis: a case report

Jayashankar CA, D. S. Somasekar, Pavan Kumar Perugu, Santosh KV, Manjunath Nandennavar, Praveen Mathew


Primary amyloidosis is a group of monoclonal plasma cell disorders, characterized by extracellular deposition of immunoglobulin light chain fibrils in multiple organs leading to progressive multiorgan dysfunction. It is a rare disease which usually occurs in elderly persons and has a poor prognosis. We report a 72-year-old male patient with chronic abdominal distension, bilateral pitting pedal edema with nephrotic range proteinuria and amyloid deposition in liver and bone marrow. Immunoelectrophoresis of serum demonstrated the presence of immunoglobulin light chains of the circulating monoclonal protein. He was treated with IV bortezomib and IV dexamethasone.


AL Amyloidosis, Proteinuria, Hepatomegaly

Full Text:



Harsh Mohan. Immunopathology including amyloidosis. In: Praveen Mohan, Tanya Mohan, Sugandha Mohan, eds. Text Book of Pathology. 5th ed. New Delhi: Jaypee brothers; 2005: 83-92.

Khan MF, Falk RH. Amyloidosis. Postgrad Med J. 2001 Nov;77(913):686-93.

Estelle Desport, Frank Bridoux, Christophe Sirac, Sebastien Delbes, Sebastien Bender, Beatrice Fernandez et al. AL Amyloidosis. Orphan J Rare Dis. 2012 Aug;7:54.

Saoji V, Chaudhari S, Gohokar D. Primary systemic amyloidosis: three different presentations. Indian J Dermatol Venerol Leprol. 2009 Jul-Aug;75(4):394-7.

Rajkumar SV, Dispenzieri A, Kyle RA. Monoclonal gammopathy of undetermined significance, waldenstrom macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment. Mayo Clin Proc. 2006;81:693-703.

Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis, tours, France, 18-22 April 2004. Am J Hematol. 2005;79:319-328.

Gertz MA, Merlini G. Definition of organ involvement and response to treatment in AL amyloidosis: an updated consensus opinion. Amyloid. 2010;17(Suppl 1):48-9.